Outcomes of Anti-CD19 CAR-T Treatment of Pediatric B-ALL with Bone Marrow and Extramedullary Relapse-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Outcomes of Anti-CD19 CAR-T Treatment of Pediatric B-ALL with Bone Marrow and Extramedullary Relapse

Published:2021-09-17 Issue: Volume: Page:
ISSN:1598-2998
Container-title:Cancer Research and Treatment
language:en
Short-container-title:Cancer Res Treat

Author:

Wan Xinyu,Yang Xiaomin,Yang Fan,Wang Tianyi,Ding Lixia,Song Lili,Miao Yan,Wang Xiang,Ma Yani,Luo Chengjuan,Tang Jingyan,Gu Longjun,Chen Jing,Tang Yanjing,Lu Jun,Li Benshang

Publisher

Korean Cancer Association

Subject

Cancer Research,Oncology

Link

http://www.e-crt.org/upload/pdf/crt-2021-399.pdf

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming the challenges of primary resistance and relapse after CAR-T cell therapy;Expert Review of Clinical Immunology;2024-05-14

2. Incidence of CD19-negative relapse after CD19-targeted immunotherapy in R/R BCP acute lymphoblastic leukemia: a review;Leukemia & Lymphoma;2023-08

3. Difference in Efficacy and Safety of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy Containing 4-1BB and CD28 Co-Stimulatory Domains for B-Cell Acute Lymphoblastic Leukemia;Cancers;2023-05-15

4. Umbilical cord blood: A promising source for allogeneic CAR-T cells;Frontiers in Oncology;2022-07-29

5. Efficacy and safety of CD19 CAR-T cell therapy for patients with B cell acute lymphoblastic leukemia involving extramedullary relapse;Journal of Zhejiang University (Medical Sciences);2022-04-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP